about
Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disordersHuman microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approachesSlipping through the Cracks: Linking Low Immune Function and Intestinal Bacterial Imbalance to the Etiology of Rheumatoid ArthritisSuppression of inflammation by helminths: a role for the gut microbiota?Selenium and inflammatory bowel diseaseBacterial Landscape of Bloodstream Infections in Neutropenic Patients via High Throughput SequencingReduced Epithelial Na+/H+ Exchange Drives Gut Microbial Dysbiosis and Promotes Inflammatory Response in T Cell-Mediated Murine ColitisThe gut microbiome in human neurological disease: A review.Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia.Differing Complex Microbiota Alter Disease Severity of the IL-10-/- Mouse Model of Inflammatory Bowel Disease.Changes in composition of caecal microbiota associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus speciesInfluence of age, reproductive cycling status, and menstruation on the vaginal microbiome in baboons (Papio anubis)Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model.Interactions between multiple helminths and the gut microbiota in wild rodentsMicrobiota-mitochondria inter-talk: consequence for microbiota-host interaction.Adaptive immunity increases the pace and predictability of evolutionary change in commensal gut bacteria.The Intersection of TNF, IBD and the Microbiome.Reproduction and Growth in a Murine Model of Early Life-Onset Inflammatory Bowel Disease.Intestinal Microbiota Is Influenced by Gender and Body Mass Index.Sasa quelpaertensis leaf extract regulates microbial dysbiosis by modulating the composition and diversity of the microbiota in dextran sulfate sodium-induced colitis miceFermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse modelLactobacillus acidophilus INMIA 9602 Er-2 strain 317/402 probiotic regulates growth of commensal Escherichia coli in gut microbiota of familial Mediterranean fever disease subjects.Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.Inflammatory diseases modelling in zebrafish.Carrageenan Gum and Adherent Invasive Escherichia coli in a Piglet Model of Inflammatory Bowel Disease: Impact on Intestinal Mucosa-associated Microbiota.Step-up Fecal Microbiota Transplantation (FMT) Strategy.Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium studyZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling.Azathioprine, Mercaptopurine, and 5-Aminosalicylic Acid Affect the Growth of IBD-Associated Campylobacter Species and Other Enteric MicrobesDeciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes.Multidomain analyses of a longitudinal human microbiome intestinal cleanout perturbation experimentPhage therapy targeting Escherichia coli-a story with no end?Gut microbiota and IBD: causation or correlation?Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD patients and healthy individuals in Iran.[Enteric microflora in inflammatory bowel disease patients].Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.Campylobacter concisus Genomospecies 2 Is Better Adapted to the Human Gastrointestinal Tract as Compared with Campylobacter concisus Genomospecies 1.Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis.A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota.
P2860
Q26777279-89E09632-D462-4C1C-B689-CFA22DF2FB70Q26779242-3B7A7475-1CF0-457B-B225-0DAB86203DA5Q27008648-E8E3BD97-E26F-46D3-A51A-3E02781AD310Q27020931-7555D0D1-95DE-4F33-B202-471D9C3EB083Q28085300-CDF573A2-EC34-4372-B6F0-6E49A04344F7Q28547252-8E732FC8-278E-4E2F-A1E2-D8FCA0099CB0Q28601112-04A1F5F1-1518-41F8-8A75-E2EFE805FDB4Q30490923-940CAE9B-A174-4826-977C-77414838C111Q30846620-2BB129AF-8F8F-44DD-8C71-0AE5A6EC046BQ33658943-511B8B7E-1A79-419F-BD14-87F02B42511AQ35227885-DC6DF21A-AB49-445B-8C22-4DB9B5586E6AQ35560135-7006311D-99E2-4B67-A0FB-CC4FF95F3AB6Q35659344-BFE5A9DE-8D92-4FA7-A688-2E9EFF6E5BBEQ35684951-33394717-CD8F-4A7B-A588-B6C225224FACQ35820966-243A82E7-ADB3-47DF-9A4C-B973B2C4B8B8Q35855014-7430F004-4D8F-4B67-B07D-44038867B8E6Q35945255-1E6645CF-A3DE-43EF-96DF-BA9A40322876Q35979738-71CDEAEB-316B-48BB-8400-025C212157CDQ36030630-C7AD58BC-B9AF-474E-84D4-2311895E935FQ36203581-CEC43870-4445-4592-B092-7A0BE0FE0057Q36212298-091A6AB8-1FF0-466A-B6A6-813E7E9E54E0Q36264671-06963CB7-510C-4946-B50E-842991E34A2DQ36477852-C0537F08-2BEE-4434-85D1-9606076D6D31Q36594979-80EE0F91-31E9-46BD-BA54-B732D2A0B97EQ36764228-91436A42-EBBB-490E-9B1B-567341BC205FQ37183267-6BC7A979-FB92-41A2-B0FE-C57D23DFAC4FQ37263314-5818F05F-4E25-45D7-A84E-B3E01C6F3259Q37663040-79A07C52-CEC9-4A59-9AF9-00B92BBAED2EQ37729532-54CA4AE5-75D7-4970-A4E6-96248E706475Q38600883-9F44B264-5690-4684-858C-036A67046018Q38618285-0AA74050-22F7-4CFF-827C-D9178C8458E5Q39038578-4710EBA3-81C7-4CA9-8932-0792E6FA2B91Q39458190-BDC4B7EB-937C-4957-BA95-87B1C90FF071Q40066779-240A15D7-DBFD-43CB-9980-4055ABF19E12Q40109637-2F95504F-36D1-4188-9601-6317DFB46076Q40397914-60CA7354-0B3E-4EBB-A6B7-CE389DD1E1F5Q40752459-A11BF6CE-573B-4054-98FB-9BAF8CE24079Q41224933-9386FC65-3E97-46A3-9ED5-8A599AA0EF16Q41287600-426B9C41-EE67-445E-A7B9-B8984CA003AAQ41550197-F45D538C-CCDC-44F5-A427-4FDFE2CDA6BF
P2860
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2012
@uk
name
Intestinal Microbes in Inflammatory Bowel Diseases
@en
Intestinal Microbes in Inflammatory Bowel Diseases
@nl
type
label
Intestinal Microbes in Inflammatory Bowel Diseases
@en
Intestinal Microbes in Inflammatory Bowel Diseases
@nl
prefLabel
Intestinal Microbes in Inflammatory Bowel Diseases
@en
Intestinal Microbes in Inflammatory Bowel Diseases
@nl
P2860
P356
P1476
Intestinal Microbes in Inflammatory Bowel Diseases
@en
P2093
R Balfour Sartor
Sarkis K Mazmanian
P2860
P356
10.1038/AJGSUP.2012.4
P577
2012-07-01T00:00:00Z